AMGEN INC

For the period ended Dec 31, 2023. Filed Feb 14, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 14, 2024

AMGN$465.23+1.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 2. PROPERTIES

Item 2.	PROPERTIES

As of December 31, 2023, we owned or leased approximately 160 properties, including properties acquired from Horizon in Deerfield, Illinois and Ireland. The locations and primary functions of significant properties are summarized in the following tables:

U.S. Location:	Manufacturing	Administrative	R&D	Sales & marketing	Warehouse	Distribution center
Thousand Oaks, CA*	P	P	P	P	P	P
San Francisco, CA			P
Deerfield, IL		P	P	P
Louisville, KY					P	P
Cambridge, MA			P
Juncos, Puerto Rico	P	P			P	P
West Greenwich, RI	P	P			P
Tampa, FL		P		P
Other U.S. cities		P		P

Corporate headquarters

ROW Location:	Manufacturing	Administrative	R&D	Sales & marketing	Warehouse	Distribution center
Brazil		P		P	P
Canada		P	P	P
China		P		P
Denmark		P	P	P
France		P		P
Germany		P	P	P
Iceland		P	P
Ireland	P	P		P	P	P
Japan		P		P
Netherlands	P	P		P	P	P
Singapore	P	P		P	P
Switzerland		P		P
United Kingdom		P	P	P
Other countries		P	P	P	P

Excluded from the information above are (i) undeveloped land and leased properties that have been abandoned and (ii) certain buildings we still own but that are no longer used in our business. Additionally, in January 2024 our U.S. manufacturing facility in New Albany, Ohio received licensure from the FDA for commercial production, and our facility in Holly Springs, North Carolina is currently under construction. There are no material encumbrances on our owned properties.

We believe our facilities are suitable for their intended uses and, in conjunction with our third-party contract manufacturing agreements, provide adequate capacity and are sufficient to meet our expected needs. See Item 1A. Risk Factors for a discussion of the factors that could adversely impact our manufacturing operations and the global supply of our products.

See Item 1. Business—Manufacturing, Distribution and Raw Materials.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.